Comparison of the systemic and intratumoral effects of tamoxifen and the aromatase inhibitor vorozole in postmenopausal patients with primary breast cancer. [electronic resource]
Producer: 20020319Description: 1026-35 p. digitalISSN:- 0732-183X
- Administration, Oral
- Aged
- Antineoplastic Agents, Hormonal -- administration & dosage
- Biomarkers, Tumor -- analysis
- Breast Neoplasms -- drug therapy
- Enzyme Inhibitors -- administration & dosage
- Female
- Follicle Stimulating Hormone -- analysis
- Humans
- Ki-67 Antigen -- analysis
- Luteinizing Hormone -- analysis
- Middle Aged
- Postmenopause
- Receptors, Estrogen -- analysis
- Receptors, Progesterone -- analysis
- Tamoxifen -- administration & dosage
- Triazoles -- administration & dosage
No physical items for this record
Publication Type: Clinical Trial; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.